患有潜在慢性肝病的西方患者的急性本地戊型肝炎：利巴韦林的作用？ - Suppr

Suppr

超能文献

Acute autochthonous hepatitis E in western patients with underlying chronic liver disease: a role for ribavirin?

作者信息

Péron J M, Dalton H, Izopet J, Kamar N

出版信息

J Hepatol. 2011 Jun;54(6):1323-4; author reply 1324-5. doi: 10.1016/j.jhep.2011.01.009. Epub 2011 Jan 31.

DOI:10.1016/j.jhep.2011.01.009

PMID:21281681

Abstract

摘要

相似文献

Acute autochthonous hepatitis E in western patients with underlying chronic liver disease: a role for ribavirin?

J Hepatol. 2011 Jun;54(6):1323-4; author reply 1324-5. doi: 10.1016/j.jhep.2011.01.009. Epub 2011 Jan 31.

Ribavirin therapy for hepatitis E virus-induced acute on chronic liver failure: a preliminary report.

Antivir Ther. 2012;17(6):1091-6. doi: 10.3851/IMP2317. Epub 2012 Aug 16.

Domestically acquired hepatitis E successfully treated with ribavirin in an Australian liver transplant recipient.

Med J Aust. 2015 Mar 2;202(4):209-11. doi: 10.5694/mja14.00453.

Monitoring hepatitis E virus fecal shedding to optimize ribavirin treatment duration in chronically infected transplant patients.

J Hepatol. 2019 Jan;70(1):206-209. doi: 10.1016/j.jhep.2018.09.011. Epub 2018 Oct 24.

Ribavirin for Chronic Hepatitis Prevention among Patients with Hematologic Malignancies.

Emerg Infect Dis. 2015 Aug;21(8):1466-9. doi: 10.3201/eid2108.150199.

Chronic Hepatitis E in a Renal Transplant Recipient: The First Report of Genotype 4 Hepatitis E Virus Caused Chronic Infection in Organ Recipient.

Gastroenterology. 2018 Mar;154(4):1199-1201. doi: 10.1053/j.gastro.2017.12.028. Epub 2018 Feb 9.

Protracted fecal shedding of HEV during ribavirin therapy predicts treatment relapse.

Clin Infect Dis. 2015 Jan 1;60(1):96-9. doi: 10.1093/cid/ciu742. Epub 2014 Sep 23.

Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection.

Gastroenterology. 2010 Nov;139(5):1612-8. doi: 10.1053/j.gastro.2010.08.002. Epub 2010 Aug 11.

Ribavirin treatment of a patient with chronic hepatitis E. First case reported in Latin America.

Acta Gastroenterol Latinoam. 2016 Jun;46(2):122-5.

Sofosbuvir shows antiviral activity in a patient with chronic hepatitis E virus infection.

J Hepatol. 2017 Jan;66(1):242-243. doi: 10.1016/j.jhep.2016.09.014. Epub 2016 Oct 1.

引用本文的文献

A patient with acute hepatitis E and intractable vomiting: a case report.

Front Med (Lausanne). 2025 Jul 21;12:1614921. doi: 10.3389/fmed.2025.1614921. eCollection 2025.

Viral hepatitis E: Clinical manifestations, treatment, and prevention.

Liver Res. 2024 Jan 6;8(1):11-21. doi: 10.1016/j.livres.2024.01.001. eCollection 2024 Mar.

Hepatitis E as a trigger for acute-on-chronic liver failure.

Clin Mol Hepatol. 2025 Feb;31(Suppl):S196-S204. doi: 10.3350/cmh.2024.0758. Epub 2024 Nov 11.

Hepatitis E infection: A review.

World J Virol. 2023 Dec 25;12(5):262-271. doi: 10.5501/wjv.v12.i5.262.

Early ribavirin for hepatitis E virus infection in patients receiving immunosuppressive therapy: a retrospective, observational study.

J Int Med Res. 2023 Jul;51(7):3000605231187941. doi: 10.1177/03000605231187941.

Treatment Options for Hepatitis A and E: A Non-Systematic Review.

Viruses. 2023 Apr 28;15(5):1080. doi: 10.3390/v15051080.

Treatment of Hepatitis E.

Adv Exp Med Biol. 2023;1417:215-226. doi: 10.1007/978-981-99-1304-6_15.

Therapeutic Advances in Viral Hepatitis A-E.

Adv Ther. 2022 Apr;39(4):1524-1552. doi: 10.1007/s12325-022-02070-z. Epub 2022 Feb 27.

Hepatitis E Virus: An emerging enigmatic and underestimated pathogen.

Saudi J Biol Sci. 2022 Jan;29(1):499-512. doi: 10.1016/j.sjbs.2021.09.003. Epub 2021 Sep 20.

Hepatitis E Virus Infection: Neurological Manifestations and Pathophysiology.

Pathogens. 2021 Dec 3;10(12):1582. doi: 10.3390/pathogens10121582.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Acute autochthonous hepatitis E in western patients with underlying chronic liver disease: a role for ribavirin?

J Hepatol. 2011 Jun;54(6):1323-4; author reply 1324-5. doi: 10.1016/j.jhep.2011.01.009. Epub 2011 Jan 31.

Ribavirin therapy for hepatitis E virus-induced acute on chronic liver failure: a preliminary report.

Antivir Ther. 2012;17(6):1091-6. doi: 10.3851/IMP2317. Epub 2012 Aug 16.

Domestically acquired hepatitis E successfully treated with ribavirin in an Australian liver transplant recipient.

Med J Aust. 2015 Mar 2;202(4):209-11. doi: 10.5694/mja14.00453.

Monitoring hepatitis E virus fecal shedding to optimize ribavirin treatment duration in chronically infected transplant patients.

J Hepatol. 2019 Jan;70(1):206-209. doi: 10.1016/j.jhep.2018.09.011. Epub 2018 Oct 24.

Ribavirin for Chronic Hepatitis Prevention among Patients with Hematologic Malignancies.

Emerg Infect Dis. 2015 Aug;21(8):1466-9. doi: 10.3201/eid2108.150199.

Chronic Hepatitis E in a Renal Transplant Recipient: The First Report of Genotype 4 Hepatitis E Virus Caused Chronic Infection in Organ Recipient.

Gastroenterology. 2018 Mar;154(4):1199-1201. doi: 10.1053/j.gastro.2017.12.028. Epub 2018 Feb 9.

Protracted fecal shedding of HEV during ribavirin therapy predicts treatment relapse.

Clin Infect Dis. 2015 Jan 1;60(1):96-9. doi: 10.1093/cid/ciu742. Epub 2014 Sep 23.

Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection.

Gastroenterology. 2010 Nov;139(5):1612-8. doi: 10.1053/j.gastro.2010.08.002. Epub 2010 Aug 11.

Ribavirin treatment of a patient with chronic hepatitis E. First case reported in Latin America.

Acta Gastroenterol Latinoam. 2016 Jun;46(2):122-5.

Sofosbuvir shows antiviral activity in a patient with chronic hepatitis E virus infection.

J Hepatol. 2017 Jan;66(1):242-243. doi: 10.1016/j.jhep.2016.09.014. Epub 2016 Oct 1.

引用本文的文献

A patient with acute hepatitis E and intractable vomiting: a case report.

Front Med (Lausanne). 2025 Jul 21;12:1614921. doi: 10.3389/fmed.2025.1614921. eCollection 2025.

Viral hepatitis E: Clinical manifestations, treatment, and prevention.

Liver Res. 2024 Jan 6;8(1):11-21. doi: 10.1016/j.livres.2024.01.001. eCollection 2024 Mar.

Hepatitis E as a trigger for acute-on-chronic liver failure.

Clin Mol Hepatol. 2025 Feb;31(Suppl):S196-S204. doi: 10.3350/cmh.2024.0758. Epub 2024 Nov 11.

Hepatitis E infection: A review.

World J Virol. 2023 Dec 25;12(5):262-271. doi: 10.5501/wjv.v12.i5.262.

Early ribavirin for hepatitis E virus infection in patients receiving immunosuppressive therapy: a retrospective, observational study.

J Int Med Res. 2023 Jul;51(7):3000605231187941. doi: 10.1177/03000605231187941.

Treatment Options for Hepatitis A and E: A Non-Systematic Review.

Viruses. 2023 Apr 28;15(5):1080. doi: 10.3390/v15051080.

Treatment of Hepatitis E.

Adv Exp Med Biol. 2023;1417:215-226. doi: 10.1007/978-981-99-1304-6_15.

Therapeutic Advances in Viral Hepatitis A-E.

Adv Ther. 2022 Apr;39(4):1524-1552. doi: 10.1007/s12325-022-02070-z. Epub 2022 Feb 27.

Hepatitis E Virus: An emerging enigmatic and underestimated pathogen.

Saudi J Biol Sci. 2022 Jan;29(1):499-512. doi: 10.1016/j.sjbs.2021.09.003. Epub 2021 Sep 20.

Hepatitis E Virus Infection: Neurological Manifestations and Pathophysiology.

Pathogens. 2021 Dec 3;10(12):1582. doi: 10.3390/pathogens10121582.